Skip Navigation

European Heart Journal 2004 25(23):2168-2169; doi:10.1016/j.ehj.2004.09.028
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bagust, A.
Right arrow Articles by Walley, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bagust, A.
Right arrow Articles by Walley, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letter to the Editor

Exploring groups at high risk of restenosis

Adrian Bagust, Ameet Bakhai, Rumona Dickson, Yenal Dundar, Ruaraidh A Hill* and Tom Walley

Liverpool Reviews and Implementation Group [LRiG], University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool L69 3GE, UK

* Corresponding author. Tel.: +44 151 79 45541; fax: + 44 151 79 45477 (E-mail: r.hill@liv.ac.uk).

The first 10% of the full text of this article appears below.

We thank Scheen and colleagues for their interest in our systematic review1 of drug-eluting coronary artery stents (DES) and congratulate them on their success in obtaining largely unpublished data for diabetic and non-diabetic subgroups for six major trials of DES. We feel it would be useful for . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?